赫索金酶作为神经退行症的中心枢纽:从代谢功能障碍到治疗创新
Shiyuan Cai1, Yanjun Liu1, Bo Liu2
1Department of Pharmacy, The People's Hospital of Miyi County, Panzhihua 617000, Sichuan, China.
Aging and disease
|November 10, 2025
概括
赫索金酶 (HK) 通过调节能量代谢和线粒体功能,对神经元的生存至关重要. 准HK为阿尔茨海默氏症和帕金森症等神经退行性疾病提供了一个有希望的治疗策略.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
背景情况:
- 神经退行性疾病影响全球超过5500万,其机制不清楚,治疗方法有限.
- 赫索基纳酶 (HK) 是一种关键的糖解酶,因其在神经元生存中的作用而越来越受认可.
- 由HK调节的代谢-线粒体合对于维持神经元健康至关重要.
研究的目的:
- 审查新出现的证据对hexokinase在神经退行症中的作用.
- 阐明将HK功能障碍与神经退行性病理联系起来的分子机制.
- 探索针对神经保护的治疗策略.
主要方法:
- 对赫索金酶,VDAC1和神经退行性疾病研究的文献综述.
- 分析涉及HK-VDAC1相互作用及其破坏的分子通路.
- 在临床前模型中检查针对HK的治疗干预措施.
主要成果:
- HK-VDAC1相互作用作为一种对神经元活力至关重要的代谢检查点.
- 功能障碍的HK和破坏的HK-VDAC1轴与阿尔茨海默病,帕金森病,ALS和HD有关.
- 病态蛋白汇聚到破坏HK-VDAC1轴,导致线粒体功能障碍和神经炎症.
- HK作为一个分子静止剂,通过代谢和信号通路控制神经元命运.
结论:
- 赫克索金酶是神经退行性疾病的一种融合治疗标.
- 通过干预,酶调制或基因疗法准HK显示了神经保护潜力.
- 针对代谢-炎症网络的组合疗法可能提供协同效益.
- 在神经退行症中,HK为早期诊断和预防策略提供了机会.
相关概念视频
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Protein Networks
4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Protein Kinases and Phosphatases
14.9K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.9K
Protein Kinases and Phosphatases
4.3K
4.3K
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K


